Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
China · Delayed Price · Currency is CNY 3.250
+0.030 (0.93%)
Sep 2, 2026, 3:00 PM CST
SHA:603718 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 213.98 | 187.87 | 271.04 | 240.72 | 299.99 | 347.29 |
Revenue Growth | -21.68% | -30.69% | 12.59% | -19.76% | -13.62% | 34.02% |
Gross Profit Gross Profit Growth | 135.12 | 135.9 | 160.65 | 120.42 | 175.38 | 188.89 |
Operating Income Operating Income Growth | 37.82 | 45.05 | 18.53 | -6.5 | 15.69 | 21.9 |
Net Income Net Income Growth | -318.22 | -311.44 | 171.18 | 62.87 | 121.61 | 53.86 |
Earnings Per Share EPS Growth | -0.49 | -0.48 | 0.26 | 0.10 | 0.19 | 0.08 |
EPS Growth | - | - | 160.00% | -47.37% | 137.50% | 700.00% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Veterinary Biological Products Veterinary Biological Products Growth | 62.39 |
Medical Instruments Medical Instruments Growth | 125.48 |
Total Total Growth | 187.87 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 345.36 | 425.14 | 517.08 | 353.22 | 392.71 | 538.63 |
Total Debt Total Debt Growth | 105.3 | 16.81 | 17.6 | 271.02 | 158.12 | 477.66 |
Net Cash (Debt) Net Cash Growth | 240.06 | 408.34 | 499.49 | 82.2 | 234.59 | 60.97 |
Net Cash Growth | -52.01% | -18.25% | 507.66% | -64.96% | 284.77% | 13.27% |
Net Cash Per Share Net Cash Per Share Growth | 0.37 | 0.63 | 0.76 | 0.13 | 0.37 | 0.09 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 43.26 | 58.83 | 46.47 | -8.37 | 292.91 | 43.63 |
Capital Expenditures CapEx Growth | -10.19 | -12.17 | -8.39 | -7.81 | -19.85 | -37.78 |
Free Cash Flow Free Cash Flow Growth | 33.07 | 46.66 | 38.08 | -16.18 | 273.06 | 5.85 |
Free Cash Flow Growth | -48.44% | 22.53% | - | - | 4564.07% | -95.62% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 63.14% | 72.34% | 59.27% | 50.02% | 58.46% | 54.39% |
Operating Margin | 17.68% | 23.98% | 6.84% | -2.70% | 5.23% | 6.30% |
Pretax Margin | -94.04% | -98.37% | 76.78% | 23.27% | 43.74% | 16.45% |
Profit Margin | -148.71% | -165.77% | 63.16% | 26.12% | 40.54% | 15.51% |
FCF Margin | 15.46% | 24.84% | 14.05% | -6.72% | 91.02% | 1.69% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.078 | - | 0.078 | 0.029 | 0.057 |
Dividend Per Share Growth | 173.17% | - | 173.17% | -49.38% | - |
Dividend Yield | 2.41% | - | 1.15% | 0.27% | 0.59% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 26.56 | 112.07 | 52.00 | 182.95 |
Forward PE | - | 81.19 | 81.19 | 81.19 | 81.19 | 81.19 |
P/FCF Ratio | 64.06 | 85.71 | 119.37 | - | 23.16 | 1683.00 |
PS Ratio | 9.90 | 21.29 | 16.77 | 29.27 | 21.08 | 28.37 |